Hemoglobin-Based Oxygen Carriers: Serious Adverse Event Mechanisms and Molecular Mitigation Strategies
- 2 July 2026
- book chapter
- Published by Springer Nature
- p. 77-82
Abstract
No abstract availableKeywords
This publication has 23 references indexed in Scilit:
- Taming hemoglobin chemistry—a new hemoglobin-based oxygen carrier engineered with both decreased rates of nitric oxide scavenging and lipid oxidationExperimental & Molecular Medicine, 2024
- Hemoglobin-Based Oxygen Carriers: Brief History, Pharmacology and Design Strategies, Review of the Major Products in Clinical Trials, On-Going Studies, and Coagulation Concerns2022
- Hemoglobin-based Oxygen Carriers: Current State-of-the-art and Novel MoleculesShock, 2019
- Mechanisms of Toxicity and Modulation of Hemoglobin-based Oxygen CarriersShock, 2019
- Users Guide to Pitfalls and Lessons Learned About HBOC-201 During Clinical Trials, Expanded Access, and Clinical Use in 1,701 PatientsShock, 2019
- Impact of acellular hemoglobin‐based oxygen carriers on brain apoptosis in ratsTransfusion, 2014
- HBOC Vasoactivity: Interplay Between Nitric Oxide Scavenging and Capacity to Generate Bioactive Nitric Oxide SpeciesAntioxidants & Redox Signaling, 2013
- Regional Blood Flow After Serial Normovolemic Exchange Transfusion With HBOC-201 (Hemopure) in Anesthetized SwineJournal of Trauma: Injury, Infection & Critical Care, 2009
- HBOC-201 as an Alternative to Blood Transfusion: Efficacy and Safety Evaluation in a Multicenter Phase III Trial in Elective Orthopedic SurgeryJournal of Trauma: Injury, Infection & Critical Care, 2008
- Cell-Free Hemoglobin-Based Blood Substitutes and Risk of Myocardial Infarction and DeathJAMA, 2008